On the Great Company podcast, Osbourne warns any medicine can be misused and links his view of Ozempic to his own struggles with body image as a kid.
Recap by typeshit. Post by @greatcompanypodcast on Instagram.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Dr. Nadolsky responds to a clip from comedian @stavvybaby2 about GLP-1s, adding a doctor's view to the joke.
He calls GLP-1 drugs useful before surgery or after regain, but says surgery stays the main option for people who need large, lasting weight loss.
An anonymous poster says people put their dramatic weight loss down to their mother's death, when it was really Ozempic they wanted to keep quiet.
A one-line stock move for the maker of Mounjaro and Zepbound, with no reason given for the gain.
Kosche lays out the peptides he uses and says he hasn't decided whether they deserve a permanent place in his routine.
Loading…